Lung Nodule on CT: What Does Your Report Mean?
The report comes in the mail, or your doctor mentions it almost as an aside: “There’s a small nodule in the lung.” For radiologists this is routine — a finding that turns up in nearly half of all chest CT scans. For the person reading the report, it is the sentence that derails the rest of the day.
Type “lung nodule” into a search engine that evening and the word cancer shows up within seconds. That is where this article starts — not with blanket reassurance, but with a calm, expert account of what a lung nodule on CT actually means, and what it doesn’t.
What a lung nodule is — and what it isn’t
A lung nodule is a rounded, well-circumscribed spot in the lung tissue measuring less than three centimeters across. On a computed tomography (CT) scan it appears as a bright density against the otherwise dark lung. Anything larger than three centimeters is called a mass rather than a nodule — a matter of naming, not of biology.
A nodule is not a diagnosis. It is a finding that needs to be put in context. All it says at first is that the radiologist saw something on the CT images that stands out from normal lung tissue. The word itself tells you nothing about the cause.
The causes are many, and the overwhelming majority are harmless. Common ones include granulomas (small knots of tissue left behind by a past infection), scarring from inflammation that has healed, enlarged lymph nodes inside the lung, and hamartomas (benign growths made of mixed tissue). More than 95 percent of all lung nodules found incidentally on CT are benign. That figure comes in part from the large US NLST trial, in which 96 percent of the nodules proved harmless even among smokers.
None of this means a nodule can be ignored. It means the odds you start from are very different from the ones fear suggests.
Why more nodules are being discovered now
Since April 2026, people covered by German statutory health insurance have had access to an organized lung cancer screening program for the first time. The Federal Joint Committee (G-BA), which decides what German statutory insurance pays for, approved the scan as a covered benefit: an annual low-dose CT (LDCT) for people at high risk.
You qualify if you are a current or former smoker aged 50 to 75, have smoked for at least 25 years, still smoke or quit less than ten years ago, and have a smoking history of at least 15 pack-years. One pack-year means smoking a pack (20 cigarettes) a day for a year.
Screening will turn up far more lung nodules — and that is the point. The goal is to catch lung cancer early, while it can still be cured. The side effect is that a lot of people will get a nodule finding that turns out, in the end, to be harmless.
Until now, nearly every lung nodule was an incidental finding — spotted on a CT ordered for something else entirely. Screening adds a new group: people who went in for the scan on purpose and come away with a finding that has to be watched. The emotional starting point is different; the way doctors work it up is the same.
What the terms in your report mean
CT reports are written in clinical language — one doctor talking to another. To a patient they can read like a foreign language. These are the terms that come up most often.
Solid nodule
“Solid pulmonary nodule in the right lower lobe, 7 mm, smooth margins.”
In plain language: in the lower right part of the lung there is a rounded, uniformly dense spot 7 millimeters across with smooth edges. “Solid” means the whole thing is made of dense tissue — unlike ground-glass changes, where the tissue is only partly clouded. Smooth margins are a feature that favors a benign cause.
Ground-glass opacity
“Focal ground-glass opacity in the left upper lobe, 12 mm.”
In plain language: in the upper left part of the lung there is a patch of faint, hazy density. Unlike a solid nodule, the tissue is not fully dense, just subtly clouded — which is where the name comes from, since it looks like frosted glass. Ground-glass opacities often have harmless causes such as inflammation or infection, but if they stick around they need careful follow-up.
Part-solid (subsolid) nodule
“Part-solid nodule in the right upper lobe, 14 mm, with a solid component of 5 mm.”
In plain language: a mixed nodule — part of it is hazy, ground-glass tissue and part of it is fully dense. The size of the solid part is what matters most clinically. Part-solid nodules get extra attention because a small share of them are slow-growing lung cancers (adenocarcinomas), even when they look stable over a long stretch of time.
Spiculation, lobulation, smooth margins
These terms describe the edge, or margin, of a nodule:
- Smooth margins: the edges are even and sharply defined — a feature that points toward something harmless.
- Lobulated: the surface is wavy, with small bulges — a nonspecific finding that shows up in benign and malignant nodules alike.
- Spiculated: fine, spike-like strands radiate out from the nodule into the surrounding tissue. Of all the shape features, spiculation is the one most strongly linked to cancer. A spiculated nodule usually needs to be worked up promptly.
Size: what the millimeters mean
Size is the single most important factor in judging risk. The Fleischner criteria (Fleischner Society 2017), used internationally, sort solid nodules into three groups:
- Under 6 mm: in patients with no particular risk factors, no follow-up is usually needed.
- 6 to 8 mm: a repeat scan after 6 to 12 months, depending on how the nodule looks and on the patient’s risk profile.
- Over 8 mm: more testing is called for — a repeat CT at three months, a PET/CT, or in some cases a tissue sample.
These thresholds are guideposts, not hard lines. Radiologists also weigh the shape of the nodule, where in the lung it sits, and the patient’s own medical history.
How radiologists assess the risk
Radiologists work through a lung nodule systematically. Size is only one piece of it; several features are read together.
Size is the starting point: the bigger the nodule, the higher the odds that it is cancer. Below 6 mm, the risk is under one percent. Between 6 and 8 mm, it is one to two percent.
Shape and margins hint at how the nodule is growing. Smooth, sharply defined edges favor a benign cause. Blurred or spiculated edges are more worrying.
Location matters, too: nodules in the upper lobes of the lungs carry a slightly higher risk of cancer than those lower down.
Growth is often what settles the question. When a solid nodule holds steady over a defined period, that points toward a harmless cause. A solid nodule that has not changed in shape or size over two years is almost certainly benign. The rule does not carry over cleanly to subsolid nodules, though: even ones that look stable can be slow-growing adenocarcinomas.
All of this serves one goal: avoiding unnecessary procedures without missing anything. The Fleischner criteria and Germany’s highest-grade (S3) clinical guideline on lung cancer give radiologists and clinicians an evidence-based framework for that balancing act.
What happens after the report — the next steps
For many patients, the hardest part is not the report itself but what comes after: waiting. A follow-up CT six months out feels like forever when the question of whether the nodule is harmless keeps circling in your head.
Even so, watchful waiting is the medically right call in most cases. The logic is simple: benign nodules stay as they are. Cancerous ones grow — and the follow-up CT picks up that growth long before it matters clinically.
What happens next depends on the size and the type of the nodule:
Small, solid nodules under 6 mm in patients with no particular risk factors (nonsmokers, no history of cancer) usually need no routine follow-up under the Fleischner criteria.
Solid nodules between 6 and 8 mm get a repeat scan after 6 to 12 months. If nothing has changed, another check follows at 18 to 24 months, depending on how the nodule looks.
Solid nodules over 8 mm are followed more closely: a CT after three months, a PET/CT scan (which measures how metabolically active the nodule is), or in some cases a biopsy to examine the tissue itself.
Subsolid and ground-glass nodules follow a schedule of their own. Because they can be cancerous even when they change very slowly, the scans come closer together and the watching period runs longer than for purely solid nodules.
When a second opinion can provide reassurance
Most lung nodules can be sorted out clearly. Not all of them can. In these situations, an independent radiological second opinion can bring clarity:
- The report says things like “cannot be excluded with certainty,” “further workup recommended,” or “requires follow-up” — and you cannot tell what that means for you in practice.
- The follow-up schedule you were given doesn’t add up — too short, too long, or with no clear reason behind it.
- The written report and what your doctor told you do not line up.
- The finding came out of the lung cancer screening program, and you want a second radiologist to confirm the assessment.
Asking for a second read says nothing about the radiologist who read the scan first — it is a normal part of careful diagnosis. When a finding may have to be tracked for months, having another specialist look at the images can give you the footing you need for the next step.
At Second View, experienced board-certified radiologists read your CT images independently and write up what they see in language you can actually use — within 48 hours of receiving the images.
Frequently asked questions
Is a lung nodule always cancer?
No. The great majority are harmless. In screening studies, more than 95 percent of the nodules found were not cancer. Common causes include granulomas, scar tissue, and enlarged lymph nodes. The answer comes from a systematic look at size, shape, and how the nodule behaves over time — not from the finding by itself.
How large can a nodule be and still be harmless?
Size alone doesn’t tell you whether a nodule is benign or malignant, but it does drive the next steps. Solid nodules under 6 mm often need no follow-up in low-risk patients. At 6 mm and above, repeat scans are recommended. At 8 mm and above, more testing is called for. The Fleischner criteria lay out the evidence behind those steps.
Why do I have to wait months instead of having surgery right away?
Because most nodules are harmless, and surgery carries risks that wouldn’t be justified in the vast majority of cases. The follow-up CTs are there to watch how the nodule behaves. A benign nodule stays the same. A cancerous one grows — and that growth shows up on the follow-up scan long before it becomes dangerous.
What is the difference between a nodule and a tumor?
“Nodule” describes what the scan shows: a rounded spot visible on CT. “Tumor” means a growth of tissue, which can be benign or malignant. Not every nodule is a tumor — plenty are scars, granulomas, or leftovers of an old infection. And not every tumor is cancer.
Can a nodule disappear again?
Yes. Nodules caused by inflammation or infection can shrink away once the underlying problem clears up. On the follow-up CT they turn out to be smaller or gone entirely. That is one of the reasons doctors watch first rather than operating right away.
This article is general information and no substitute for being examined and advised by a doctor who knows your case. If symptoms come on suddenly or your health changes, reach out to a doctor or an emergency department without waiting. Last medical review: May 2026.
Sources and further reading
- MacMahon H et al. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology 2017.
- S3-Leitlinie Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. Leitlinienprogramm Onkologie (AWMF), Version 3.0, 2024.
- Gemeinsamer Bundesausschuss (G-BA). Richtlinie zur Lungenkrebs-Früherkennung mittels Niedrigdosis-Computertomographie. 2025.
- Callister ME et al. British Thoracic Society Guidelines for the Investigation and Management of Pulmonary Nodules. Thorax 2015.
- Chen Y et al. Prevalence and management of pulmonary nodules: a systematic review and meta-analysis. J Thorac Dis 2024.